Free Virtual Consultations. Corona Virus Related Cases Click Here.
ACCIDENT NEWS

2 Injured in Crash on Interstate 8 Near 70th Street


Wrong-Way Driver Causes La Mesa Accident

La Mesa, CA (March 26, 2020) – Two people were injured in a wrong-way crash in La Mesa. The accident occurred at around midnight on March 26 on Interstate 8.

A Ford SUV was traveling west in the eastbound lanes of Interstate 8, near 70th Street. Moments later, the vehicle collided head-on with a BMW. Both drivers were trapped inside their vehicles. The SUV caught fire. The SUV’s 28-year-old driver and the BMW’s 45-year-old driver were both hospitalized with life-threatening injuries.

#La Mesa

#91942


April 3, 2020

1 Killed in Crash on Highway 12 Near Oakmont Drive

Tree-Trimming Truck, Honda Collide in Fatal Santa Rosa Accident...


March 2, 2020

Man Killed in Crash on 170 Freeway Near Roscoe Boulevard

3 Vehicles Involved in Fatal North Hollywood Accident...


October 23, 2019

2 Killed in Crash on Highway 50 Near 13th Street

Motorcycle, Car Collide in Fatal Sacramento Accident Sacramento, CA (October 21...

Free Police Report Request

We offer free consultation. No office visit required, we will get back to you within 24 hours.

  • This field is for validation purposes and should be left unchanged.

What can we do for you?

  • Answer your legal question.
  • Provide a Free Case Evaluation.
  • Schedule an appointment.

Why Choose Us?

  • Available 24/7
  • Trusted Since 1990
  • Local to You
  • Recovered $350,000,000
  • 5 Star Reviews
  • Free Case Evaluation
  • VIP Service
  • No Win, No Fee

Latest Law Post


May 22, 2020

Johnson & Johnson Discontinues Talc-Based Baby Powder

baby powder new Johnson & Johnson discontinued its talc-based baby powders in the United States and Canada because thousands of lawsuits claiming it was contaminated with asbestos created a sales decline.


May 18, 2020

FDA Issues Warnings To Two Manufacturers Of Breast Implants

The U.S. Food and Drug Administration (FDA) just issued warning letters to two manufacturers of breast implants for failing to comply with regulatory requirements. The FDA sent a warning letter to Allergan for failure to comply with requirements to conduct post-approval studies assessing the risks and long-term safety of two separate breast implant models. Both breast implant models were voluntarily recalled last year. The FDA also sent a warning letter to Ideal Implant Incorporated. That letter was sent for failing to comply with adverse event reporting requirements and current good manufacturing practice requirements. The letter was prompted by an inspection which was conducted earlier in 2020.